Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
An open, multicenter, phase Ib/II study to evaluate the efficacy, safety and pharmacokinetics
of CT041 autologous CAR T-cell injection in patients with advanced gastric/ gastroesophageal
junction adenocarcinoma and pancreatic cancer